AU2002367140A1 - Human sglt homolog promoter and use thereof - Google Patents

Human sglt homolog promoter and use thereof

Info

Publication number
AU2002367140A1
AU2002367140A1 AU2002367140A AU2002367140A AU2002367140A1 AU 2002367140 A1 AU2002367140 A1 AU 2002367140A1 AU 2002367140 A AU2002367140 A AU 2002367140A AU 2002367140 A AU2002367140 A AU 2002367140A AU 2002367140 A1 AU2002367140 A1 AU 2002367140A1
Authority
AU
Australia
Prior art keywords
human sglt
sglt homolog
homolog promoter
promoter
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002367140A
Inventor
Keiji Iwamoto
Nozomi Katayama
Mihoko Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002367140A1 publication Critical patent/AU2002367140A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002367140A 2001-12-27 2002-12-26 Human sglt homolog promoter and use thereof Abandoned AU2002367140A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001396791 2001-12-27
JP2001-396791 2001-12-27
PCT/JP2002/013651 WO2003056005A1 (en) 2001-12-27 2002-12-26 Human sglt homolog promoter and use thereof

Publications (1)

Publication Number Publication Date
AU2002367140A1 true AU2002367140A1 (en) 2003-07-15

Family

ID=19189125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002367140A Abandoned AU2002367140A1 (en) 2001-12-27 2002-12-26 Human sglt homolog promoter and use thereof

Country Status (2)

Country Link
AU (1) AU2002367140A1 (en)
WO (1) WO2003056005A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5696156B2 (en) 2009-11-02 2015-04-08 ファイザー・インク Dioxa-bicyclo [3.2.1] octane-2,3,4-triol derivative

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4218669C1 (en) * 1992-06-05 1993-09-02 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De
US6486299B1 (en) * 1998-09-28 2002-11-26 Curagen Corporation Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
JP2004512016A (en) * 2000-05-26 2004-04-22 インサイト・ゲノミックス・インコーポレイテッド Transporters and ion channels
JP2004513618A (en) * 2000-07-07 2004-05-13 インサイト・ゲノミックス・インコーポレイテッド Transporters and ion channels
JP2004511222A (en) * 2000-07-28 2004-04-15 キュラジェン　コーポレイション Proteins and nucleic acids encoding them
WO2002053738A1 (en) * 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Novel proteins and dnas thereof

Also Published As

Publication number Publication date
WO2003056005A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
EP1187075B8 (en) Human body detector
AU2002357643A1 (en) The human mob-5 (il-24) receptors and uses thereof
AU2002327185A1 (en) Diagnostic methods and devices
AU2002255952A1 (en) Short bioactive peptides and methods for their use
AU2002346453A1 (en) Absorbent garment with incorporated skin wellness ingredients
AU2002332614A1 (en) Disposable rainwear
WO2003099841A9 (en) Peptides and the use thereof in darkening the skin
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002319286A1 (en) Skin treatment
AU2001267213A1 (en) Cdna for human methylenetetrahydrofolate reductase and uses thereof
AU2002210916A1 (en) Endoscope attachment and endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2002250041A1 (en) Putative human enzymes
AU2001274309A1 (en) Phosphoglycan messengers and their medical uses
AU2002367140A1 (en) Human sglt homolog promoter and use thereof
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001260615A1 (en) Human pgc-1 promoter
AU4456800A (en) Human hac3
AU2003275713A1 (en) Use of sglt homolog
AU2002344829A1 (en) Human ugrp (uteroglobin-related protein) 1 promoter and its use
AU2002356679A1 (en) Clusianon isomers and use thereof
AU2001266932A1 (en) Human lyases
AU2001261785A1 (en) Vdup1 promoter and methods of use thereof
AU2001274318A1 (en) Phosphoglycan messengers and their medical uses
AU2002367139A1 (en) Human netrin receptor and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase